Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Apr 30;29(4):730. doi: 10.1007/s12282-022-01367-9

Correction to: Validation of a nuclear grading system for resected stage I–IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trial

Hitoshi Tsuda 1,✉, Masafumi Kurosumi 2, Futoshi Akiyama 3, Shinji Ohno 4, Shigehira Saji 5, Norikazu Masuda 6, Akihiko Shimomura 7, Nobuaki Sato 8, Shintaro Takao 9, Shozo Ohsumi 10, Yutaka Tokuda 11, Hideo Inaji 12, Toru Watanabe 13
PMCID: PMC9225968  PMID: 35499664

Correction to: Breast Cancer 10.1007/s12282-022-01350-4

In the original publication of the article, the affiliation of the co-author, Norikazu Masuda, should be changed from “National Hospital Organization Osaka National Hospital, Osaka, Japan” to “Nagoya University Graduate School of Medicine, Nagoya, Japan”.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Breast Cancer (Tokyo, Japan) are provided here courtesy of Springer

RESOURCES